PHARMACOVIGILANCE OF HYPOLIPIDEMIC DRUGS - A RETROSPECTIVE STUDY OF THE DATA OF THE FRENCH SYSTEM OF PHARMACOVIGILANCE

被引：0
|
作者：
LAVARENNE, J
机构：
来源：
THERAPIE | 1991年 / 46卷 / 05期
关键词：
ADVERSE EFFECTS; HYPOLIPIDEMIC DRUGS; FIBRATES; DATA-BANK;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The methodology of a retrospective study of the side-effects of the most prescribed lipid lowering drugs, essentially fibrates, is described. This study concerns the last 5-years reports to the French System of Pharmacovigilance, centralized in the common data-base located in Lyon. During this period 36 875 reports were recorded, only 409 in which an hypolipidemic drug is stated as "suspect" (according to WHO's definitions) were selected and analyzed. All fibrates were involved, those most frequently implicated being the most widely prescribed (e.g. fenofibrate represents half of the reports).
引用
收藏
页码：345 / 346
页数：2
相关论文
共 50 条
  • [21] Pharmacovigilance for veterinary drugs
    Müntener, CR
    Gassner, B
    Demuth, DC
    Althaus, FR
    Zwahlen, R
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2004, 146 (11): : 499 - 505
  • [22] Pharmacovigilance and clinical trials: Experience of a French pharmacovigilance department
    Brocvielle, H.
    Thomas, L.
    Le Louet, H.
    DRUG SAFETY, 2007, 30 (10) : 962 - 963
  • [23] Hepatic and biliary side effects of tramadol chlorhydrate: a retrospective study of cases reported to french pharmacovigilance system
    Pierre, S.
    Disson-dautriche, A.
    Combret, S.
    Grandvuillemin, A.
    Sgro, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 28 - 28
  • [24] Drugs and memory: a case/non-case study in the French Pharmacovigilance database
    Chavant, F.
    Favreliere, S.
    Perault-Pochat, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 32 - 32
  • [25] PHARMACOVIGILANCE OF ANTIHYPERTENSIVE DRUGS
    HUGUES, FC
    DELLAS, JA
    MARCHE, J
    THERAPIE, 1982, 37 (02): : 197 - 206
  • [26] Medication Errors in Old Patients (MEDEROP): A Retrospective Study of the French Pharmacovigilance Network
    Guillaumin, M.
    Grau, M.
    Laroche, M. L.
    Valnet Rabier, M. B.
    Annie-Pierre, J-B.
    DRUG SAFETY, 2021, 44 (12) : 1461 - 1461
  • [27] Pharmacovigilance: The French experience
    Descotes, Jacques
    TOXICOLOGY LETTERS, 2006, 164 : S26 - S27
  • [28] The French pharmacovigilance database system - Some examples
    Moore, N
    Noblet, C
    KreftJais, C
    Lagier, G
    Ollagnier, M
    Imbs, JL
    THERAPIE, 1995, 50 (06): : 557 - 562
  • [29] Idelalisib-associated colitis: monocentric real-life retrospective study and analysis of French pharmacovigilance data
    Bertoliatti, G.
    Breal, C.
    De Witasse-Thezy, T.
    Beuvon, F.
    Guerin, C.
    Faillie, J. L.
    Treluyer, J. M.
    Bouscary, D.
    Vignon, M.
    Chouchana, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 76 - 77
  • [30] Drugs inducing violence: a review of the French PharmacoVigilance DataBase (FVDB)
    Rouve, N.
    Telmon, N.
    Bagheri, H.
    Pathak, A.
    Lapeyre-Mestre, M.
    Franchitto, N.
    Rouge, D.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 97 - 97
12345